about
What do we know about steroids metabolism and 'PK/PD approach' in AKI and CKD especially while on RRT--current status in 2014Renal and neurological side effects of colistin in critically ill patientsBiomarkers in critical illness: have we made progress?Facing acid-base disorders in the third millennium - the Stewart approach revisited.Newly designed CRRT membranes for sepsis and SIRS--a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review.The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment.Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge'Biomarking' infection during continuous renal replacement therapy: still relevant?Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!Phosphate induced crystal acute kidney injury - an under-recognized cause of acute kidney injury potentially leading to chronic kidney disease: case report and review of the literatureNew insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic acute kidney injury.Biomarkers for early diagnosis of AKI in the ICU: ready for prime time use at the bedside?Continuous renal replacement therapy-related strategies to avoid colistin toxicity: a clinically orientated review.Critical care nephrology: could it be a model of multidisciplinarity in ICU nowadays for other sub-specialities - the jury is outA fresh look into the pathophysiology of ischemia-induced complications in patients with chronic kidney disease undergoing hemodialysis.Prevention and treatment of sepsis-induced acute kidney injury: an update.Statins and the Kidney: Friend or Foe?Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration.Peri-operative fluid strategy and post-operative acute kidney injury in cardiac surgery patients: any role for pre-operative statin therapy?Higher colistin dose during continuous renal replacement therapy: look before leaping!Renal tubular acidosis with hyperchloremic acidosis: harmless with a sting?Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?Predicting acute kidney injury in severe trauma. A biomarker breakthrough?Presepsin and sepsis-induced acute kidney injury treated with continuous renal replacement therapy: will another promising biomarker bite the dust?Metabolic and coagulation effects of citrate: down to the last detail!To counteract or to clear high-mobility group box-1 protein in influenza A (H1N1) infection? That may become the question.Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe.Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?Congenital cervical kyphosis in a child associated with tetraparesis: case report.Biomarkers of inflammation during continuous renal replacement therapy: sensors, players, or targets? A reply to the letter by Villa et al.Ropivacaine 3.75 mg/ml, 5 mg/ml, or 7.5 mg/ml for cervical plexus block during carotid endarterectomy.Con: Dialy- and continuous renal replacement (CRRT) trauma during renal replacement therapy: still under-recognized but on the way to better diagnostic understanding and prevention.Monitoring the safety of antiepileptic medication in a child with Brugada syndrome.Frey's syndrome after elective thyroidectomy: a case report.A rare cause of dyspnea due to chylothoraxDelayed recovery following laparoscopic partial hepatectomyEvaluating sepsis during continuous dialysis: are biomarkers still valid?Immunoadsorption versus therapeutic plasma exchange. Will fibrinogen make the difference?
P50
Q26995350-CF27BD36-950D-40EB-B1D3-EA09F768674FQ27499294-622DDFCE-4461-40E9-9863-16FACCC806D3Q28077254-EA40D784-D72D-46B9-ADFB-80EC0319310BQ33768404-4A1C9688-8466-48B4-AE21-DD2361DDF5AAQ34329616-33542782-9ADF-4F80-B68E-70BE9EEB5013Q35021183-90F6373B-0CCC-47AA-B220-D07057F8AF80Q35765398-5F43F546-87B4-4A70-B4DE-AAD53C7C80D0Q35809468-EA7F771C-CC79-41E2-8D61-60BA8AA6C85EQ36349316-2FCBEC9E-91E6-4E7A-BD61-EED719B4AEBAQ36709540-66114F4F-195D-4ADB-BC7F-D47EE20C89C5Q37969597-56773BA8-CBF5-4984-94EC-D518D9EE6ABBQ38022745-C11AD006-EB17-4206-AEF4-5E7AE9BA9F83Q38237313-E66F727A-C7B0-4A2B-AABC-6F8BC09941CBQ38282867-2D794009-B5D3-404F-B3E3-5080985B2BC3Q38385002-93FA4211-A79E-478A-B19D-A374A23569C8Q38675436-70871183-B00F-4460-8DD2-8F5C49A646ADQ39036453-B87F0C8D-CE7C-4C32-8D1F-345C5E644EB2Q39401310-1C30F4EF-901B-4162-B519-F53A4A8DBB96Q41175527-870D14B8-D330-4814-AB19-EB51DB40F3B6Q42056256-9D7A2BAE-96AE-4DFB-83E6-CA519BB52CEBQ42566190-E48DD9E1-B3B5-4807-861F-7E99412D005BQ42582768-5F65EE13-128C-4602-9B0A-BF7F5B3F7296Q42930685-AE74A91E-037E-43EE-A69A-1046805D84F0Q43065983-9C0DD24B-6E01-4C4F-8588-EA8A034463A8Q43107482-4FDD4047-295E-4E91-9078-4E2A7075A889Q43107503-6CA93C6E-7AB5-444E-B0EF-27B51227CB25Q43107507-6B803A7E-E3FE-40BF-9E7D-AB36E97C7924Q43160855-031B25CB-4FB4-4615-8C71-93AC5E54269BQ43171911-C2CAE444-713C-48FC-ABF0-73BBD26361AEQ43185471-090E5C7A-6ACD-419C-B401-494EA05A6B59Q43201761-42DE8146-5A13-47EE-8D79-8BDEDDA0C428Q44238210-4D45804E-1903-4AE0-869B-87B1434A4A8DQ45014331-808E41B1-C75F-402D-90CF-5D942ED0C302Q45335842-DDD45205-0C39-4D7B-AD31-2B8F804DB309Q46129271-9D3CDA72-5B2A-4649-9931-5B0B2657EFDDQ48460730-FEEE6C30-DB9E-4A11-8442-7942D3ADE002Q84767785-AA811DA5-E744-422B-A76D-2B68BFC99719Q84984794-AE19469B-FC97-46A1-8E07-A6E30FA69D92Q85849473-7601C804-7B94-467E-87FB-A4BE04E1E856Q86267835-FDC48F16-9539-42A0-95DB-57F142D63012
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Viola Van Gorp
@ast
Viola Van Gorp
@en
Viola Van Gorp
@es
Viola Van Gorp
@nl
type
label
Viola Van Gorp
@ast
Viola Van Gorp
@en
Viola Van Gorp
@es
Viola Van Gorp
@nl
prefLabel
Viola Van Gorp
@ast
Viola Van Gorp
@en
Viola Van Gorp
@es
Viola Van Gorp
@nl
P106
P31
P496
0000-0002-6225-7392